25.06.2015, 12:42
LifeWatch AG receives CE marking for continuous vital signs monitoring
OREANDA-NEWS. LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that it has received CE Marking of Conformity for its continuous Vital Signs Monitoring Service.
The wireless, patch-based vital signs monitoring system makes vital signs monitoring faster, easier and more convenient for both, patients and hospital staff. It will allow for early detection of vital sign changes and faster interventions, increased nursing ef?ciency and higher patient satisfaction.
The Vital Signs Patch is an easy-to-use cable-free sensor worn on a patient's upper chest. It is intended to be used on adult patients in a clinical environment for the continuous, non-invasive monitoring of ECG, heart rate, respiration rate, surface temperature, arterial blood oxygen saturation and body position. It will be available in two versions (with and without ECG) and is connected with an easy-to-use wireless supporting system which provides medical information and alerts remotely to hospital staff.
Dr. Stephan Rietiker, CEO of LifeWatch, stated: "This clearance represents a significant technological development for LifeWatch and continues to strengthen our position as an innovational leader in digital health. It allows us to start the market acceptance testing for vital signs monitoring in Europe and is a big step towards offering services for patients outside of the US."
The results of our European market acceptance tests will support the US launch and global roll-out.
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products.
The wireless, patch-based vital signs monitoring system makes vital signs monitoring faster, easier and more convenient for both, patients and hospital staff. It will allow for early detection of vital sign changes and faster interventions, increased nursing ef?ciency and higher patient satisfaction.
The Vital Signs Patch is an easy-to-use cable-free sensor worn on a patient's upper chest. It is intended to be used on adult patients in a clinical environment for the continuous, non-invasive monitoring of ECG, heart rate, respiration rate, surface temperature, arterial blood oxygen saturation and body position. It will be available in two versions (with and without ECG) and is connected with an easy-to-use wireless supporting system which provides medical information and alerts remotely to hospital staff.
Dr. Stephan Rietiker, CEO of LifeWatch, stated: "This clearance represents a significant technological development for LifeWatch and continues to strengthen our position as an innovational leader in digital health. It allows us to start the market acceptance testing for vital signs monitoring in Europe and is a big step towards offering services for patients outside of the US."
The results of our European market acceptance tests will support the US launch and global roll-out.
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products.
Комментарии